The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
RECEPTOR.AI
Boston, United States
B
11-50 Employees
2021
Key takeaway
RECEPTOR.AI offers a comprehensive small molecule drug discovery platform that utilizes artificial intelligence and computational chemistry to enhance precision and personalized medicine. Their approach focuses on creating novel drugs with improved selectivity and efficacy, addressing challenging drug targets through tailored workflows.
Reference
Service
Drug Discovery Services
Aganitha
Warren, United States
B
11-50 Employees
2017
Key takeaway
Aganitha AI Inc specializes in developing in silico solutions that accelerate the drug discovery and development process, utilizing computational sciences and AI to enhance research efficiency for both small molecules and biologics. By partnering with global pharmaceutical companies, Aganitha aims to bring novel medicines to market faster while reducing experimental costs.
Reference
Core business
Aganitha AI Inc – In silico solutions for Biopharma and Biotech R&D | Aganitha
Ainnocence
San Francisco, United States
B
11-50 Employees
2021
Key takeaway
Ainnocence is revolutionizing drug discovery with its generative AI systems that significantly reduce costs and risks associated with developing new therapies. Their technology enables rapid screening of billions of compounds, allowing researchers to focus on innovative treatments for challenging diseases.
Reference
Core business
Ainnocence – AI Driven Drug Discovery
The most Disruptive AI based system For drug discovery on the market Our platform uses AI to help you speed up your drug discovery processes. Together we can make a big difference New Project? Small Molecules? Large Molecules? Ainnocence harnesses artificial intelligence and machine learning tools to deliver advanced analytics to underpin scientific decision making. Our platform offers…
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
ChemDiv
San Diego, United States
B
501-1000 Employees
1990
Key takeaway
ChemDiv is a global leader in drug discovery, utilizing Hybrid Artificial Intelligence (AI) and Machine Learning (ML) to enhance the drug discovery process. Their innovative approach allows for quick and effective access to a diverse collection of small molecules, significantly advancing the development of drug candidates across various therapeutic areas.
Reference
Core business
AI gets access to big novel chemistry space for quick and effective drug discovery - Chemdiv
Adimab
Lebanon, United States
B
101-250 Employees
2007
Key takeaway
Adimab specializes in providing a comprehensive platform that enhances the discovery and optimization of therapeutic leads, making it highly relevant for AI drug discovery. Their innovative methods and engineered yeast technology support scientists in identifying and developing bispecific formats that can significantly impact therapeutic efficacy.
Reference
Product
Technology | Adimab
Premier Human Antibody Discovery and Optimization
Absci
Vancouver, United States
B
101-250 Employees
2011
Key takeaway
The company, Absci, specializes in generative AI drug discovery, focusing on creating biologics more efficiently. Their Integrated Drug Creation™ platform leverages advanced AI to streamline the process of designing and validating new antibody candidates, significantly reducing the time to bring new drugs to clinical trials.
Reference
Product
Drug Discovery Platform | Absci
Absci's Integrated Drug Creation™ platform unifies drug discovery and cell line development enabling the production of next-generation biologics.
Quintara Discovery, Inc.
Hayward, United States
B
11-50 Employees
2013
Key takeaway
Quintara Discovery, Inc. specializes in drug discovery and development, offering high-quality in vitro ADME profiling, bioanalysis services, and dedicated assay development and compound screening. Their expertise in designing assays and analyzing data positions them as a valuable partner in the drug discovery process.
Reference
Core business
About – Quintara Discovery Inc.
Quintara Discovery, Inc. has been acquired by Frontage Laboratories, Inc. QDI Advantages At QDI, we have accumulated extensive knowledge and insight in designing high-fidelity assays, obtaining and analyzing critical data, and prioritizing compounds to advance to the next discovery and development stage. All experiments are performed in California by an experienced and talented
Intelligencia
New York, United States
B
51-100 Employees
2017
Key takeaway
Intelligencia AI is revolutionizing the pharmaceutical industry by leveraging AI innovations to enhance the drug discovery process. Their focus on minimizing risks and streamlining development ultimately aims to bring lifesaving treatments to patients more quickly.
Reference
Product
intelligencia.ai - Accelerating Innovation in Drug Development.
ReviveMed
Cambridge, United States
B
1-10 Employees
2016
Key takeaway
ReviveMed utilizes an AI-based metabolic platform for precision therapeutics, highlighting its focus on AI-driven drug discovery through advanced metabolomic studies. Their approach aims to enhance the understanding of diseases and patient physiology by improving the detection of metabolites.
Reference
Core business
revivemed – AI Driven Drug Discovery
Pyxant Labs
Colorado Springs, United States
B
51-100 Employees
2000
Key takeaway
The company is dedicated to accelerating the development of life-saving therapies for pharma and biotech clients by offering innovative bioanalytical and spatial biology solutions. They emphasize the use of Mass Spectrometry Imaging to enhance early drug development, facilitating efficient drug discovery and strategic decision-making.
Reference
Service
Bioanalysis Discovery - Aliri Bioanalysis
When navigating drug discovery, it is critical to strategically balance project timelines and investments. Learn more about our quick turnaround solutions.
Technologies which have been searched by others and may be interesting for you:
The AI drug discovery industry in the United States is rapidly evolving, driven by advancements in machine learning and data analytics. Key considerations include understanding the regulatory landscape, as the Food and Drug Administration (FDA) oversees the approval processes for new drugs, which can impact timelines and costs. Additionally, researchers should be aware of the challenges associated with data quality and integration, as well as the need for robust validation methods to ensure the reliability of AI-generated insights. Opportunities abound, particularly in the areas of personalized medicine and rare disease treatment, where AI can expedite the identification of viable drug candidates. The competitive landscape is intense, with startups and established pharmaceutical companies alike investing heavily in AI technologies. Collaborations between tech firms and academic institutions are also prevalent, fostering innovation and knowledge sharing. Environmental concerns are becoming more significant as companies focus on sustainable practices in drug development. Understanding the global market relevance is essential, as the U.S. leads in AI drug discovery, influencing trends and standards worldwide. Keeping abreast of these factors can provide a comprehensive view of the industry for potential investors or job seekers.
Some interesting numbers and facts about your company results for Ai Drug Discovery
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 3104 |
| Amount of suitable service providers | 2593 |
| Average amount of employees | 51-100 |
| Oldest suiting company | 1990 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Ai Drug Discovery
What are related technologies to Ai Drug Discovery?
Based on our calculations related technologies to Ai Drug Discovery are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Ai Drug Discovery?
Start-Ups who are working in Ai Drug Discovery are RECEPTOR.AI, Ainnocence
Which industries are mostly working on Ai Drug Discovery?
The most represented industries which are working in Ai Drug Discovery are IT, Software and Services, Biotechnology, Other, Pharmaceuticals, Healthcare
How does ensun find these Ai Drug Discovery Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
